Sustainability in motion

Hosted across two days in Lugano, Switzerland, speakers at the DCAT Sustainability Summit tackled the sustainability question. Broadly speaking, the sustainability question remains unanswered. Not in the sense of whether sustainability should be a priority – consensus among biopharma industry professionals has fallen in its favour for quite some time— but rather in exactly how this should be done. Indeed, framing it as the ‘sustainability question’ is a false premise, because sustainability encompasses a diverse set of interlocking factors. Each of these factors must be considered not only within the context of one’s individual business, but also the landscape of the broader biopharma industry.

LATEST VIDEO

Latest news

12th December 2024

Lonza Investor Update 2024 Outlines Strategy, New Organizational Structure and Guidance

11th December 2024

Bryan Patterson to lead as Senior Vice President of Government Business Development & Capture

10th December 2024

Bespak and OzUK further strengthen low Global Warming Potential pMDI development service

10th December 2024

EUROAPI moves into a new chapter with new Governance and Leadership

6th December 2024

Changes in Siegfried's senior management team

5th December 2024

Newcells Biotech raises additional funding from investors

5th December 2024

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

5th December 2024

Navin Molecular Awarded Gold Medal by EcoVadis, Recognising Achievements in Business Sustainability

4th December 2024

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market

4th December 2024

FairJourney Biologics appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering

4th December 2024

Circio announces novel circVec 3.0 generation and circular mRNA half-life up to 75 times longer than linear mRNA in vivo

This week’s featured articles

Innovation in mAb purification using affinity chromatography resins based on proprietary rProtein A

Unpacking Global Biopharma Business Relations with Ashu Tandon

A surprising comparison between CDMOs and auto makers

Pushing boundaries in ADC development

Views from a round table at DCAT Week

People make the difference

Partnered with top industry events and organisations